Form D · Other
Abreos Biosciences, Inc.
San Diego, CA · CIK 0001636983
Offering snapshot reported Sep 17, 2020 · SEC filing
- Reported sold
- $5.63M Offering amount: $5.63M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 8, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 17, 2020 | Initial | $5,626,227 | No comparison | 16 | SEC filing |
| Jun 5, 2017 | Amendment | $1,200,000 | $1,050,000vs Jan 6, 2017 | 10 | SEC filing |
| Jan 6, 2017 | Initial | $150,000 | No comparison | 1 | SEC filing |
| Apr 18, 2016 | Initial | $475,000 | No comparison | 4 | SEC filing |
| Mar 16, 2016 | Amendment | $240,000 | $65,000vs Mar 18, 2015 | 3 | SEC filing |
| Mar 18, 2015 | Initial | $175,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375819
Total amount sold includes $4,148,354.79 of cancellation of indebtedness and $1,477,872.93 of new cash.
Source: Form D, filed Sep 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter Haberz | Director |
| Bradley Messmer | Director, Executive |
| Neil Senturia | Director |
Issuer details
Industry: Other (See others in industry)
Address:
5448 Pire Ave.
San Diego, CA, 92122
San Diego, CA, 92122